Moderna announced the results of the study. Identify the company’s vaccine Capable of preventing COVID-19 British and South African breeds
–
“Moderna” reveals immunity from COVID-19 vaccine Should live for at least 1 year
Scientists find COVID-19 strain South Africa Cannot be prevented by plasma
Experts point out COVID-19 Mutants from South Africa may be drug-resistant.
On Jan 25, Moderna Company The developer of the COVID-19 vaccine “mRNA-1273” stated that the vaccine was effective in producing antibodies against the COVID-19 virus. British mutants “B.1.1.7” and South Africa “501Y.V2” have.
Moderna said that If two doses of the COVID-19 vaccine are used, “the prevention of COVID-19 is expected. New born species that can be detected up until now “
A company study found that the British COVID-19 mutant had no significant impact on the effectiveness of the mRNA-1273 vaccine, but there were concerns that the vaccine might be slightly less effective in the South African strains.
“It has been observed that COVID-19 vaccine Resulting in COVID-19 The South African breed is about 6 times less neutral compared to other breeds. “
But the company insists The vaccine will still be effective. “Even with reduced efficiency But that level is still higher than the benchmark assessed to be effective in disease prevention. ”
COVID-19 The British mutant has spread in more than 45 countries, while South Africa has appeared in more than 20 other countries.
Compiled from CNN.
– – .
